Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kubicka

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Oncogene|December 22, 1999
2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expressionC Trautwein, M Will, S Kubicka, et al.
Gut|October 1, 1995
Clinical relevance of mutations in the precore genome of the hepatitis B virusH Tillmann, C Trautwein, D Walker, et al.
Gastroenterology Research and Practice|September 23, 2016
Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized TrialsR-D Hofheinz, U Ronellenfitsch, S Kubicka, et al.
Journal of Medical Economics|November 13, 2013
Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancerT Rautenberg, U Siebert, D Arnold, et al.
The Journal of Biological Chemistry|November 5, 1999
p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesisS Kubicka, F Kühnel, L Zender, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Inhibition of transthyretin-met30 expression using Inosine(15.1)-Hammerhead ribozymes in cell cultureM J Pröpsting, S Kubicka, J Genschel, et al.
Deutsche Medizinische Wochenschrift (1946)|August 6, 2004
[Prognosis of hepatocellular carcinoma according to new staging classifications]M Caselitz, N Masche, P Flemming, et al.
The Journal of Biological Chemistry|February 29, 2000
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitisF Kühnel, L Zender, Y Paul, et al.
Cancer Gene Therapy|November 4, 2000
IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomasM K Tietze, T Wuestefeld, Y Paul, et al.
The Journal of Biological Chemistry|January 9, 1999
The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitroT Rakemann, M Niehof, S Kubicka, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Oncogene|December 22, 1999
2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expressionC Trautwein, M Will, S Kubicka, et al.
Gut|October 1, 1995
Clinical relevance of mutations in the precore genome of the hepatitis B virusH Tillmann, C Trautwein, D Walker, et al.
Gastroenterology Research and Practice|September 23, 2016
Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized TrialsR-D Hofheinz, U Ronellenfitsch, S Kubicka, et al.
Journal of Medical Economics|November 13, 2013
Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancerT Rautenberg, U Siebert, D Arnold, et al.
The Journal of Biological Chemistry|November 5, 1999
p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesisS Kubicka, F Kühnel, L Zender, et al.
Biochemical and Biophysical Research Communications|February 13, 2001
Inhibition of transthyretin-met30 expression using Inosine(15.1)-Hammerhead ribozymes in cell cultureM J Pröpsting, S Kubicka, J Genschel, et al.
Deutsche Medizinische Wochenschrift (1946)|August 6, 2004
[Prognosis of hepatocellular carcinoma according to new staging classifications]M Caselitz, N Masche, P Flemming, et al.
The Journal of Biological Chemistry|February 29, 2000
NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitisF Kühnel, L Zender, Y Paul, et al.
Cancer Gene Therapy|November 4, 2000
IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomasM K Tietze, T Wuestefeld, Y Paul, et al.
The Journal of Biological Chemistry|January 9, 1999
The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitroT Rakemann, M Niehof, S Kubicka, et al.
Pageof 7